Zimmer Biomet Holdings 负债 2024

Zimmer Biomet Holdings Aktienanalyse

Zimmer Biomet Holdings在做什么？

Zimmer Biomet Holdings Inc is a global company in the medical technology industry that provides innovative products and solutions for orthopedic, dental, and surgical applications. The company was formed through the merger of Zimmer Holdings Inc and Biomet Inc in 2015 and is headquartered in Indiana, USA. The history of Zimmer Biomet Holdings dates back to 1927 when Justin Zimmer founded Zimmer Manufacturing Company, which specialized in the production of orthopedic instruments and prostheses. In 1939, the company introduced the first modular hip endoprosthesis and over the years established itself as a leading provider of orthopedic implants and instruments. Biomet Inc was founded in 1977 with the goal of developing groundbreaking solutions for orthopedic implants. Both companies grew rapidly through acquisitions, strategic partnerships, and innovations before eventually merging. The business model of Zimmer Biomet Holdings focuses on supporting patients and medical professionals in improving quality of life and health. The company offers a wide range of products and services tailored to the needs of patients and medical professionals. These range from joint implants, spine, and knee instruments to digital solutions and patient care services. The company operates in various divisions specializing in different areas of medical technology. The Joint Reconstruction division offers a comprehensive range of implants for hips, knees, shoulders, and elbows, as well as instruments required for orthopedic and surgical procedures. The Surgical division provides products and solutions for surgical procedures, including spine, sports, and trauma surgery. Dental supplies products for dentistry, including implants, instruments, and digital solutions. Additionally, there is the Craniomaxillofacial and Thoracic Surgery division, which focuses on providing care for patients with bone and soft tissue tumors, as well as facial trauma reconstruction. Zimmer Biomet Holdings products are distributed in over 100 countries worldwide and are recognized by medical professionals and patients alike. Some of the most well-known products include the NexGen hip and knee prostheses, Trabecular Metal implants, and digital solutions for patient care such as the Zimmer Biomet mymobility service. In addition to its products and services, Zimmer Biomet Holdings pursues a variety of initiatives and partnerships to improve healthcare and patient outcomes. This includes research projects in collaboration with universities, research institutions, and medical societies, as well as the exchange of best practices among medical professionals. Overall, Zimmer Biomet Holdings has established itself as a leading provider of innovative products and solutions for orthopedic, dental, and surgical applications. With its comprehensive range of products and services and global presence, the company sets standards for healthcare and patient care. Zimmer Biomet Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

负债的详细信息

Zimmer Biomet Holdings的债务结构理解

Zimmer Biomet Holdings的总债务是指该公司欠外部各方的累积金融义务。这可能包括短期和长期贷款、债券、贷款和其他金融工具。评估公司的债务对于评估其财务状况，风险概况以及运营和扩展业务的能力至关重要。

年对年对比

通过对Zimmer Biomet Holdings多年债务结构的分析，可以洞察公司的财务策略和稳定性。债务的减少可能暗示了财务实力和运营效率，而债务的增加可能表明投资增长或潜在的财务挑战。

对投资的影响

投资者会密切关注Zimmer Biomet Holdings的债务，因为这会影响公司的风险和收益概况。过度的债务可能导致财务压力，而适度并且管理良好的债务可能是增长和扩张的催化剂。这使得债务成为投资评估的重要一环。

债务波动的解读

Zimmer Biomet Holdings债务水平的变化可能归因为各种运营和策略因素。债务的增加可能旨在资助扩张项目或提高运营能力，而债务的减少可能意味着利润的实现或是一种减小财务风险和杠杆效应的方法。

关于Zimmer Biomet Holdings股票的常见问题

Zimmer Biomet Holdings今年的债务有多高？

Zimmer Biomet Holdings今年的债务水平为5,352.1 USD。

Zimmer Biomet Holdings的债务与去年相比有多高？

Zimmer Biomet Holdings的债务与去年相比增长了0.59% 上升

Zimmer Biomet Holdings的投资者高额债务会有什么后果？

对于Zimmer Biomet Holdings的投资者来说，高额债务可能构成风险，因为它会使公司的财务状况变得较弱，可能会影响其履行义务的能力。

Zimmer Biomet Holdings的投资者低债务会有什么后果？

低债务意味着Zimmer Biomet Holdings拥有强大的财务地位，并且能够履行其义务，而不会导致其财务负担过重。

Zimmer Biomet Holdings的债务增加对公司会有什么影响？

Zimmer Biomet Holdings的债务增加可能会影响公司的财务状况，从而导致其财务负担增加。

Zimmer Biomet Holdings的债务减少会对公司产生什么影响？

将Zimmer Biomet Holdings的债务降低可以增强公司的财务状况并提高其履行财务义务的能力。

Zimmer Biomet Holdings的债务受哪些因素影响？

影响Zimmer Biomet Holdings负债的一些因素可能包括投资、收购、运营成本和营业收入的发展。

为什么Zimmer Biomet Holdings的债务对投资者如此重要？

Zimmer Biomet Holdings的债务对投资者来说很重要，因为它是公司财务稳定性的指标，并且能向投资者提供有关公司如何履行其财务义务的信息。

Zimmer Biomet Holdings可以采取哪些战略措施来改变债务状况？

为了改变债务状况，Zimmer Biomet Holdings可以采取包括削减成本、增加收入、出售资产、接受投资或合作伙伴关系等措施。公司必须对其财务状况进行彻底审查，以确定最佳的战略措施来改变其债务状况。

Zimmer Biomet Holdings支付多少股息？

在过去的12个月中，Zimmer Biomet Holdings支付了0.96 USD 的股息。这相当于大约0.89 %的股息收益率。在未来的12个月内，Zimmer Biomet Holdings预计将支付0.97 USD的股息。

Zimmer Biomet Holdings的股息收益率有多高？

Zimmer Biomet Holdings当前的股息收益率为0.89 %。

Zimmer Biomet Holdings什么时候支付股息？

Zimmer Biomet Holdings按季度支付股息。这些股息将在, , , 月份分发。

Zimmer Biomet Holdings的股息有多安全？

Zimmer Biomet Holdings 在过去18年里每年都支付了股息。

Zimmer Biomet Holdings的股息有多高？

预计未来12个月的股息将达到0.97 USD。这相当于0.89 %的股息收益率。

Zimmer Biomet Holdings位于哪个行业？

Zimmer Biomet Holdings 被分配到“健康”板块。

Wann musste ich die Aktien von Zimmer Biomet Holdings kaufen, um die vorherige Dividende zu erhalten?

要获得Zimmer Biomet Holdings在支付的0.24 USD的最后一笔股息，你必须在的除息日之前持有该股票于你的账户中。

Zimmer Biomet Holdings最后一次支付股息是什么时候？

上一次股息发放日期为。

Zimmer Biomet Holdings在2023年的股息是多少？

在2023年，Zimmer Biomet Holdings 分配了0.96 USD作为股息。

Zimmer Biomet Holdings 的股息是以哪种货币支付的？

Zimmer Biomet Holdings的股息将以USD的形式分配。